Unione Europea - italiano - EMA (European Medicines Agency)

amgen europe b.v. - blinatumomab - linfoma di leucemia linfoblastica a cellule precursori - agenti antineoplastici - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

biomed ag - magnesio - compresse effervescenti - magnesii aspartatis hydrochloridum trihydricum 1.844 g corresp. magnesium 7.5 mmol corresp. magnesium 182.3 mg, acidum citricum, natrii hydrogenocarbonas, natrii carbonas, kalii hydrogenocarbonas, macrogolum 6000, silica colloidalis anhydrica, acesulfamum kalicum, aspartamum 12.5 mg, aromatica (citron) corresp. saccharum 1.36 mg pro compresso corresp. natrium 138 mg, kalium 100 mg. - magnesiumpräparat - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

biomed ag - magnesio - soluzione iniettabile i. v. - magnesii aspartatis hydrochloridum trihydricum 738 mg corresp. magnesium 3 mmol corresp. magnesium 73 mg, aqua ad iniectabile ad solutionem pro 10 ml. - magnesio prodotto - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

biomed ag - magnesio - concentrato per soluzione per infusione - magnesii aspartatis hydrochloridum trihydricum 9.836 g corresp. magnesium 40 mmol corresp. magnesium 972.2 mg, aqua ad iniectabile q.s. ad solutionem pro 50 ml. - magnesio prodotto - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

opella healthcare italy s.r.l. - magnesio pidolato - magnesio pidolato

Italia - italiano - Ministero della Salute

mida international srl -

Unione Europea - italiano - EMA (European Medicines Agency)

novo nordisk a/s - insulina degludec - diabete mellito - farmaci usati nel diabete - trattamento del diabete mellito negli adulti.

Unione Europea - italiano - EMA (European Medicines Agency)

janssen-cilag international n.v.    - ponesimod - sclerosi multipla recidivante-remittente - immunosoppressori - ponvory is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.

Italia - italiano - Ministero della Salute

natura service srl - capsule - magnesio marino – estratto secco di rizomi di dioscorea (dioscorea oppositifolia l.) titolata 16 % in diosgenina - estratto secco di parti aeree (solo verdi) di trifoglio rosso (trifolium pratense l.) titolato 8% in isoflavoni – estratto secco di strobili di luppolo (humulus lupulus l.) — estratto secco di radici di kudzu (pueraria montana var. lobata (willd.) sanjappa & pradeep) titolato 40% in isoflavoni — cellulosa microcristallina - magnesio stearato – vitamina b6 (piridossina). capsula vegetale tipo 0. - menopausa - assumere due capsule al giorno.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

eumedica pharmaceuticals ag - buprenorphinum - sublingualtabletten - buprenorphinum 0.2 mg ut buprenorphini hydrochloridum, lactosum monohydricum corresp. lactosum 28.349 mg, mannitolum, maydis amylum, povidonum k 30, acidum citricum, natrii citras dihydricus corresp. natrium 0.036 mg, magnesii stearas, pro compresso. - analgeticum - synthetika